Sivuyisana nawe ngokufumana iSatifikethi se-MHRA se-COVID-19

Njengeyona marike inkulu yokugqibela kuMbindi Mpuma, iSaudi Arabia ikwinqanaba lokuqala kwinkcitho yezempilo yomntu ngamnye kulo mmandla.Ngo-2020, uhlahlo lwabiwo-mali lukarhulumente lwabele i-167 yeebhiliyoni zeerari (malunga ne-44.5 yeebhiliyoni zeedola) kwishishini lezempilo.Nangona kunjalo, iinkampani zasekhaya eSaudi Arabia zibandakanyeka ikakhulu ekwenzeni izinto ezisetyenziswayo okanye zisebenza njengabasasazi beenkampani zangaphandle, kwaye uninzi lwezixhobo zonyango zihlala zithunyelwa zivela kwamanye amazwe.Ke ngoko, imakethi yesixhobo sonyango eSaudi Arabia inkulu kakhulu.I-DEKRA Certification UK Ltd iqinisekiswe yi-Medicines, iTekhnoloji kunye ne-Arhente yoLawulo lweeMveliso zezeMpilo (i-MHRA) njengenye yezigqeba ezine zesatifikethi zase-UK ngoku ezinikezelwe kwisiqinisekiso sezixhobo zonyango zase-UK ukuqinisekisa ukhuseleko kunye nokusebenza kwezixhobo ezinikezelwa ngokukhuselekileyo kuluntu lwase-UK. .I-DEKRA ibe ngumbutho wokuqala ukugqiba inkqubo esanda kutyunjwa, apho nayiphi na inhlangano enokuthi ihambe ngoku ngaphambi kokuba ivunyelwe ukuba iqinisekise izixhobo zonyango e-UK.Iibhodi zokuqinisekisa ziyimibutho etyunjwe yi-MHRA ejongene nokuvavanya ukuba ngaba abavelisi kunye nezixhobo zabo zonyango zihambelana ne-UK Medical Devices Regulations 2002. Abavelisi babefuneka ukuba bafake izicelo kwii-certifiers zase-UK zokuqinisekisa ngaphandle kwezixhobo ezinomngcipheko omncinci.Kuphela emva kokuba i-UK Conformity Assessment (UKCA) iVavanywe ukuba iimveliso zabo zingathengiswa kwimarike yase-UK (eNgilani, eWales naseScotland).Emva kovavanyo olufanelekileyo, iqumrhu elivunyiweyo lesatifikethi linokuqinisekisa imveliso, livumela umenzi ukuba afake uphawu lwe-UKCA kwiimveliso zalo eziqinisekisiweyo.Igosa le-MHRA uLaura Squire uthe: “Oku linyathelo elibalulekileyo ekuqinisekiseni ukuba abaguli kulo lonke elase-UK bayafikelela kwizixhobo zonyango ezikumgangatho ophezulu.Amaqumrhu aqinisekisayo adlala indima ephambili ekunikezelweni kwezixhobo zonyango kwaye ukwandisa umthamo kubalulekile kuphuhliso oluyimpumelelo lwenkqubo yolawulo lwezixhobo zonyango zase-UK. "Inkqubo yovavanyo oluneenkcukacha lwe-MHRA yenzelwe ukuqinisekisa ukuba nawuphi na umbutho onqwenela ukuqinisekisa isixhobo sonyango unako ukwenza uvandlakanyo olunobulungisa nolunenjongo kwaye unenkqubo efanelekileyo yokulawula umgangatho kunye nezixhobo ezifanelekileyo.I-MHRA ngoku ivavanya izicelo ezivela kweminye imibutho emithandathu ukuze ibe ngamaqumrhu agunyazisiweyo.(Umthombo: National Trade Bureau, Ministry of Economic Affairs) Okwangoku, SEJOYIkhasethi yoVavanyo ye-SARS-CoV-2bafumene iMHRA certification and can be sold in  the United Kingdom. Welcome to inquire from major distributors in United Kingdom. poct@sejoy.com 0571-81957782 https://www.sejoy.com/covid-19-solution-products/ Isebe lethu le-biochemical lasungulwa kwi-2009, kwaye i-platform ye-immune chromatography yasungulwa ngo-2015. Ngokuxhomekeke kuphando oluqinileyo kunye neqela lophuhliso, ngokuthe ngcembe siye saseka imigca emithathu yeemveliso ezinkulu: i-eugenics, iziyobisi, kunye nezifo ezithathelwanayo.Imigca emithathu yemveliso ephambili ngoku iseke inkqubo epheleleyo yoshishino yophando nophuhliso, imveliso, kunye nokuthengisa.Sibonelela ngoluhlu olutyebileyo lweemveliso zokuxilonga zebhayoloji kubasebenzisi kwihlabathi liphela.Kwixesha elizayo, iiplatifomu ezinjengama-tumor markers kunye nabamakishi be-myocardial baya kusekwa ukuze bahlale betyebisa umgca wemveliso kunye nokubonelela abathengi ngeemveliso eziphezulu kunye nezisombululo.Ukuze kuliwe nobhubhane, uSejoy uphehlelele ezi zixhobo zine zilandelayo zovavanyo lwe-COVID-19 ukunciphisa ifuthe lobhubhane.Uvavanyo olukhawulezayo lwe-COVID-19 legG/lgM,SARS-CoV-2 antigen ngokukhawulezauvavanyo, I-SARS-CoV-2 i-antibody engathathi hlangothiuvavanyo, kwayeikiti yovavanyo lomkhuhlanezonke ziphuhliswe ukunceda abasebenzisi bathathe amanyathelo okuthintela kwangaphambili kunye nokunciphisa umngcipheko wosulelo.Phakathi kwabo, iSARS-CoV-2 antigen ngokukhawulezauvavanyouphumelele uvavanyo lukaPaul Ehrlich - Institut (PEI) ngugunyaziwe waseJamani ngokusebenza kwayo okuhle kakhulu.YethuSARS-CoV-2 antigen ngokukhawulezauvavanyokulula ukuyisebenzisa, kwaye iziphumo zinokufumaneka ngokukhawuleza kwimizuzu eyi-10, ngovakalelo oluphezulu kunye neenkcukacha.Ngenxa yoko, sibe ngabavelisi bokuqala kwishishini ukufumana isatifikethi se-EU se-CE kwiimveliso ezizivavanyileyo.Inkampani yethu iya kuqhubeka nokuziqhelanisa nomsebenzi wenkampani "yokudala iimveliso zodidi lokuqala kunye nokukhathalela impilo yabantu", kunye nokubonelela abathengi ngeenkonzo ezikumgangatho ophezulu!